From molecules to populations and back: KGHRI clinician-scientists highlight translational medicine at Queen’s
Health research is entering an exciting new phase at Kingston’s academic and medical research institutions, and three clinician-scientists from the KGH Research Institute have taken to the airwaves to talk about it.
Drs. Stephen Archer, Paula James and Mark Ormiston were recently profiled on Blind Date with Knowledge, a new Queen’s radio program highlighting Queen’s University research.
The researchers shared their experiences of working in the Queen’s Cardiopulmonary Unit (QCPU), a unique integrated research environment for translational medicine targeting heart, lung, blood and vascular diseases, and which opened in Queen’s Biosciences Complex last fall.
Their panel discussion, “The Translational Journey,” gives listeners an inside view of the infrastructure and people driving the QCPU -- from its innovative “molecules to populations, back to molecules” approach, to its pending launch of a first-in-Canada Translational Medicine program.
Dr. Archer, director of QCPU and Tier 1 Canada Research Chair in Mitochondrial Dynamics and Translational Medicine, describes the impact of these often-interrelated diseases, and the role of the facility and its investigators in advancing knowledge of them. He also talks about his broader vision for a Translational Institute of Medicine (TIME) at Queen’s, aimed at building the university’s research competitiveness.
Dr. Ormiston, Assistant Professor, Biomedical and Molecular Medicine and Tier 2 Canada Research Chair in Regenerative Cardiovascular Medicine, gives listeners an overview of how the facility’s combination of state-of-the-art equipment and integrated, bench-to-bedside approach enables scientists and clinicians with diverse interests to share thoughts, test fresh ideas and stimulate new collaborations.
And Dr. James, Professor of Medicine specializing in blood diseases, talks about how the QCPU’s translational approach is being integrated into a first-in-Canada Translational Medicine Graduate Program, in which Masters students and PhD candidates will have unique opportunities to interact with patients, learning about disease from the patient’s perspective, as part of their educational curriculum.
Blind Date with Knowledge airs biweekly on CFRC at 101.9 fm.